China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 14.13
-0.43 (-2.95%)
Sep 11, 2026, 3:04 PM CST
SHE:300294 Market Cap
SHE:300294 has a market cap or net worth of 7.13 billion as of September 11, 2026. Its market cap has decreased by -44.80% in one year.
Market Cap
7.13B
Enterprise Value
4.38B
Revenue
1.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.13
ChartMarket Cap Chart
Since March 8, 2012, SHE:300294's market cap has increased from 2.94B to 7.13B, an increase of 142.26%. That is a compound annual growth rate of 6.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 7.13B | -37.48% |
| Dec 31, 2025 | 11.40B | -25.36% |
| Dec 31, 2024 | 15.27B | -10.10% |
| Dec 29, 2023 | 16.98B | -7.88% |
| Dec 30, 2022 | 18.44B | -4.67% |
| Dec 31, 2021 | 19.34B | 35.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liaoning Chengda Biotechnology | 8.36B |
| Vcanbio Cell & Gene Engineering Corp., | 8.22B |
| Chongqing Genrix Biopharmaceutical | 8.20B |
| Chengdu Easton Biopharmaceuticals | 8.08B |
| Aurisco Pharmaceutical | 7.75B |
| Beijing Hotgen Biotech | 7.72B |
| Daan Gene | 7.59B |
| Innovita Biological Technology | 7.36B |